AMCP We're the people who help patients get the medications they need at a cost they can afford. Join Us Close

Most Popular

Prepublication Overview – AMCP Format for Formulary Submissions 4...

AMCP will release Version 4.1 of the AMCP Format for Formulary Submissions in December 2019.


What is Managed Care Pharmacy?

AMCP webinar that gave a general overview of managed care pharmacy.


Drug Utilization Review

Drug utilization review (DUR) is defined as an authorized, structured, ongoing review of prescribing, dispensing and use of medication. DUR encompasses a drug review against predetermined criteria that results in changes to drug therapy when these criteria are not met.


How do payers utilize the AMCP eDossier System for pre-approval i...

AMCP webinar that reviewed research and evidence that can support the opportunity to use the AMCP eDossier System as a potential safe harbor mechanism.


AMCP Partnership Forum on Prior Authorization Develops Recommenda...

Press Release: Focusing on what’s best for the patient, leveraging technology to perform real-time benefit checks, and developing trust and transparency among stakeholders are some of the suggestions to emerge from AMCP’s recent Partnership Forum on “Optimizing Prior Authorization for Appropriate Medication Selection.”


Biosimilars in the US: Current Status, Barriers to Utilization &a...

AMCP webinar that provided an overview of the current state of biosimilars in the US, description of some barriers to utilization, discussion of real-world data and how stakeholders may use real-world evidence to inform treatment and coverage decisions, and an update on the efforts of BBCIC.


AMCP Addiction Treatment Advisory Group (ATAG)

Recognizing the widespread and devastating nature of the opioid crisis, AMCP formed the Addiction Treatment Advisory Group in 2015 based on the recommendation from the AMCP Partnership Forum, Breaking the Link between Pain Management and Opioid Use Disorder.


Medication Errors

Medication errors are among the most common medical errors, harming at least 1.5 million people every year. The extra medical costs of treating drug-related injuries occurring in hospitals alone are at least to $3.5 billion a year, and this estimate does not take into account lost wages and productivity or additional health care costs.


Maintaining the Affordability of the Prescription Drug Benefit

The purpose of this paper is to explain how managed care organizations (MCOs) are able to secure lower drug prices from pharmaceutical manufacturers as part of an effort to control drug expenditures.